Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Ethnopharmacological relevance</h3><p>Xianglian Pill (XLP), a traditional Chinese pharmaceutical preparation for the treatment of gastrointestinal disease, possessing anti-inflammatory, anti-microbial and analgesic activities, may represent a promising candidate for the treatment of antibiotic-associated diarrhea (AAD).</p><p><em>Aim of the study</em>: This study aimed to unravel the underlying mechanism of XLP on the amelioration of AAD.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>AAD was induced by intragastric administration of a mixture of cefuroxime and levofoxacin (300 mg/kg.bw + 200 mg/kg.bw) for five consecutive days. Then AAD mice were treated with XLP at the dose of 500, 1000 and 2000 mg/kg.bw, respectively for 5 days. The physical manifestations, diarrhea status were monitored during the drug delivery. Histopathology of colon, intestinal microbiota, inflammatory cytokines, tight junction protein and short chain fat acids (SCFAs) were determined.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Mice received cefuroxime and levofoxacin for 5 days developed medium to severe diarrhea. XLP treatment, however, mitigated the diarrhea status. Further evaluation revealed that XLP promoted the recovery of mucosa, maintained the integrity of tight junction, attenuated the inflammatory disorders, restored intestinal microbiota and increased SCFAs level in faeces.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>XLP ameliorates AAD by restoring intestinal microbiota and attenuating mucosal damage.</p>

What problem does this paper attempt to address?

The problem this paper attempts to address is the exploration of the mechanism by which Xianglian Pill (XLP) improves antibiotic-associated diarrhea (AAD). Specifically, the study aims to reveal how XLP improves AAD by restoring the gut microbiota and alleviating mucosal damage. The paper mentions that AAD is a common complication of antibiotic treatment, with an incidence rate varying between 5%-35% depending on the type of antibiotic used. AAD not only severely hinders disease recovery but can also be life-threatening. Although the pathogenesis of AAD is still under investigation, it is generally believed that antibiotics disrupt the gut microbiota, reduce beneficial bacteria, and increase the number of facultative anaerobes, leading to secondary infections and mucosal damage. Xianglian Pill is a traditional Chinese medicine formulation, with main ingredients including Fructus Evodiae and Rhizoma Coptidis, which have anti-inflammatory, antibacterial, and analgesic effects. However, there is limited research on the effects of XLP on AAD, particularly concerning the gut microbiota. Therefore, this study experimentally verified the improvement effects of XLP on AAD and explored its potential mechanisms.

Xianglian Pill ameliorates antibiotic-associated diarrhea by restoring intestinal microbiota and attenuating mucosal damage